Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization

Size: px
Start display at page:

Download "Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization"

Transcription

1 Journal of Medical Microbiology (2004), 53, DOI /jmm Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization Eijiro Ozaki, 1 Haru Kato, 1 Hiroyuki Kita, 1 Tadahiro Karasawa, 1 Tsuneo Maegawa, 1 Youko Koino, 1 Kazumasa Matsumoto, 2 Toshihiko Takada, 2 Koji Nomoto, 2 Ryuichiro Tanaka 2 and Shinichi Nakamura 1 Correspondence Tadahiro Karasawa karasawa@med.kanazawau.ac.jp 1 Department of Bacteriology, Graduate School of Medical Science, Kanazawa University, Kanazawa , Japan 2 Yakult Central Institute for Microbiological Research, Tokyo , Japan Received 4 July 2003 Accepted 17 November 2003 The aim of the present study was to investigate the colonization status of Clostridium difficile in healthy individuals. In total, 139 healthy adults from two study groups were examined at intervals of 3 months. Among the 18 positive subjects, the number of subjects from whom C. difficile was isolated once, twice, three times or four times was 10 (55.6 %), three (16.7 %), two (11.1 %) and three (16. 7 %), respectively. In the student group, different subjects were colonized by different PCR ribotype/pfge types. However, the same PCR ribotype/pfge types of C. difficile were isolated from different subjects in the employee group, indicating that cross-transmission may have occurred in this group. Continuous colonization by the same PCR ribotype/pfge type was only observed in three subjects. C. difficile-positive subjects were significantly more densely colonized by enterococci (P, 0.05) than C. difficile-negative subjects: subjects that were found to be C. difficile-positive three or four times appeared to have higher concentrations of enterococci. The present results demonstrate that, although colonization by a C. difficile strain is transient in many cases, there are healthy individuals that are colonized persistently by C. difficile. They also suggest that dense colonization of the intestine by enterococci may be associated with C. difficile colonization. INTRODUCTION Clostridium difficile is the principal pathogen that causes antibiotic-associated diarrhoea and colitis (Lyerly et al., 1988). It has been well documented that this organism spreads nosocomially and causes hospital outbreaks of C. difficile-associated diarrhoea (CDAD) in various clinical settings (Cartmill et al., 1994; Samore et al., 1996). In the hospital setting, infected and colonized patients and contaminated environments have been implicated as potential sources of C. difficile (Gerding et al., 1986). C. difficile colonization of asymptomatic humans has been studied by various groups (Nakamura et al., 1981; Viscidi et al., 1981; Wilson et al., 1982; Kobayashi, 1983; Aronsson et al., 1985). Recently, we reported the colonization and transmission of C. difficile in healthy individuals in Japan. We also demonstrated that C. difficile could be reisolated from one-third of Present address: Department of Bacterial and Blood Products, National Institute of Infectious Diseases, Tokyo , Japan. Abbreviation: CDAD, C. difficile-associated diarrhoea. C. difficile-positive subjects after a half-year interval; half of these latter subjects were found to harbour a different strain on the second isolation (Kato et al., 2001). The aim of the present study was to further investigate the colonization status of C. difficile in healthy individuals. Moreover, intestinal microflora of C. difficile-positive and -negative subjects was compared, in order to analyse various host-related factors that may affect C. difficile colonization. METHODS Subjects. In total, 139 healthy adults (age range, years; median, 22 years) from two study groups were examined by stool culture for intestinal colonization by C. difficile (Table 1). The study groups were different from those in our previous study (Kato et al., 2001). None of the subjects had had diarrhoea or had been administered antimicrobial agents for at least 4 weeks before examination. One group, which consisted of 85 individuals, was a class of university students and the other, which comprised 54 individuals, was a group of employees at a company. For the student group, all subjects were examined three times at intervals of 3 months. Subjects who were C. difficile-positive in at least & 2004 SGM Printed in Great Britain IP:

2 E. Ozaki and others Table 1. Asymptomatic intestinal colonization by C. difficile in healthy subjects Group Age in years (median) Time of examination No. (%) of C. difficilepositive subjects Student (n ¼ 85) February (7.1) (21) June (5.9) October (2.4) Employee (n ¼ 54) March (7.4) (50) July (13.0) November (5. 6) March (5. 6) one of the three examinations were examined once more, i.e. four times in total. All subjects in the employee group were examined four times at intervals of 3 months. Examination of intestinal microflora was carried out for seven C. difficile-positive subjects in the student group (Table 2; S-1, S-2, S-3, S-4, S-5, S-6 and S-7) and nine age-matched, C. difficilenegative subjects that were also from the student group. Bacterial isolation and identification. Stool specimens were collected and frozen at 80 8C until they were used for isolation of C. difficile. In examinations of intestinal microflora, stool specimens were collected immediately after defecation and were put into an anaerobic jar with an AnaeroPack (Mitsubishi Gas Chemical Company). Culture was started within 1 day of collection. For isolation of C. difficile, stool specimens were homogenized with an equal volume of ethanol for spore selection and were cultured on cycloserine/cefoxitin/mannitol agar (CCMA) (Kato et al., 2001). To investigate possible colonization of an individual by multiple strains, colonies (a maximum of five) were isolated randomly from the primary culture plate for each specimen and subcultured on CCMA. C. difficile was identified as described previously (Kato et al., 1998). Examinations of intestinal microflora were performed by using the following selective and non-selective media: VLM (total anaerobes; Becton Dickinson) (Morotomi et al., 1981), VLM-KV (Bacteroides; Becton Dickinson) (Morotomi et al., 1981), MTP (bifidobacteria; Eikennkagaku) (Morotomi et al., 1981), CW Table 2. Types of C. difficile isolates from healthy subjects All 137 isolates, representing a maximum of five (1 5) colonies from each specimen, were examined. NT, Non-typable by PFGE, due to DNA degradation;, C. difficile-negative. Group/subject PCR ribotype/pfge type and toxin gene type* of isolates obtained at examination First Second Third Fourth Student: S-1 /, A þ B þ /, A þ B þ /, A þ B þ /, A þ B þ S-2 sbt/r59, A B sbt/r59, A B mnu/r699, A þ B þ hyk/r112, A B S-3 /NT,A þ B þ /NT,A þ B þ /NT,A þ B þ S-4 fzi/r55, A þ B þ mfh/r393, A B S-5 mwd/r331, A B mhw/r994, A þ B þ S-6 g3/r20, A B S-7 mmt/r9, A B Employee: C-1 hyk/r112, A B ntt/r115, A þ B þ ntt/r115, A þ B þ ntt/r115, A þ B þ C-2 ntt/r115, A þ B þ ntt/r115, A þ B þ ntt/r115, A þ B þ C-3 yb51/r426, A þ B þ yr84/r840, A þ B þ C-4 yb16/r129, A B C-5 yb63/r171, A B C-6 ymm/r464, A þ B þ C-7 ntt/r115, A þ B þ C-8 yb77/nt,a B C-9 yb51/r426, A þ B þ C-10 yt31/r1217, A B C-11 yb51/r426, A þ B þ *A þ B þ, Toxin A-positive, toxin B-positive; A B, toxin A-negative, toxin B-negative. 168 IP: Journal of Medical Microbiology 53

3 C. difficile colonization in healthy adults (lecithinase-positive clostridia; Nikkenseibutsu), LBS (lactobacilli; Becton Dickinson), TSA (total aerobes; Nikkenseibutsu), DHL (Enterobacteriaceae; Nikkenseibutsu), COBA (enterococci; Becton Dickinson) (Petts, 1984) and #110 (staphylococci; Nikkenseibutsu). Stool samples were homogenized and diluted serially (tenfold) with anaerobic dilution buffer (1. 7mM KH 2 PO 4,1. 3mM K 2 HPO 4,7. 7 mm NaCl, 1. 7 mm (NH 4 ) 2 SO 4,0. 2 mm MgSO 4,0. 2 mm CaCl 2,28mMNa 2 CO 3, 3mML-Cysteine.HCl, % resazurin). A 50 ìl aliquot of diluted samples from 10 1 to 10 8 was spread on each plate and incubated under either anaerobic or aerobic conditions. A 500 ìl aliquot of diluted samples from 10 6 to 10 9 was spread on MLV and MLV-KV. The number of c.f.u. [log c.f.u. (g stool) 1 ] was calculated after incubation. The Mann Whitney U test was used for statistical analysis. Typing of C. difficile isolates. The toxin gene type of the isolates was determined by a previously described PCR assay system (Kato et al., 2001). In this system, C. difficile strains were classified as toxin A- positive, toxin B-positive (A þ B þ ), toxin A-negative, toxin B-positive (A B þ ) or toxin A-negative, toxin B-negative (A B ). Typing analysis by using PCR ribotyping and PFGE was performed as described previously (Kato et al., 2001). Isolates with patterns that differed by one or more major bands were assigned to different PCR ribotypes; differences in faint bands were ignored. Major PFGE types were defined by differences in more than three fragments; these major types were subtyped further according to the criteria described by Tenover et al. (1995). RESULTS resolved into 19 ribotypes (Table 2). Four isolates were not typable by PFGE, due to DNA degradation during sample processing. The 30 PFGE-typable isolates were classified into 17 major types. Among the four non-typable isolates, two PCR ribotypes were identified. All isolates with the same PFGE type showed the same PCR ribotype; in other words, one PFGE type corresponded to one PCR ribotype. In the student group, different subjects were colonized by different PCR ribotype/pfge types, whereas the same PCR ribotype/ PFGE types of C. difficile were isolated from different subjects in the employee group: ntt/r115 was isolated from subjects C-1, C-2 and C-7 and yb51/r426 was isolated from subjects C-3, C-9 and C-11. Continuous colonization by the same PCR ribotype/pfge type was observed in three subjects: S-1 (isolated four times), S-3 (three times) and C-2 (three times) (Table 2 and Fig. 1). On the other hand, the PCR ribotype/pfge type changed in the other subjects (S-2, S-4, S-5, C-1 and C-3). It is of note that in subjects S-2 and C-1, from whom C. difficile was isolated four times, the same PCR ribotype/pfge type was observed on the second and third examinations, respectively. Regarding the toxin gene type, 22 (65 %) and 12 (35 %) of the 34 subjects were colonized by A þ B þ and A B C. difficile, respectively. Asymptomatic colonization and persistence in healthy adults In both groups, C. difficile-positive individuals were identified at all examinations (which were performed three times in the student group and four times in the employee group) (Table 1). Colonization rates ranged from 2. 4to13. 0%.In general, C. difficile was isolated from 34 (7. 1 %) of 478 samples. In the student group, seven subjects who were C. difficile-positive at any of the first, second or third examinations were examined one additional time. In the fourth examination, four subjects were found to be positive for C. difficile. In the student group, the number of subjects from whom C. difficile was isolated once, twice, three times or four times was two (subjects S-6 and S-7, 2. 4 %), two (S-4 and S-5, 2. 4 %), one (S-3, 1. 2 %) and two (S-1 and S-2, 2. 4 %), respectively (Table 2). In the employee group, the number of subjects from whom C. difficile was isolated once, twice, three times or four times was eight (C-4 to C-11, %), one (C-3, 1. 9 %), one (C-2, 1. 9 %) and one (C-1, 1. 9 %), respectively. Overall, among the 18 C. difficile-positive subjects, the number from whom C. difficile was isolated once, twice, three times or four times was 10 (55. 6 %), three (16. 7 %), two (11. 1 %) and three (16. 7 %), respectively. A maximum of five colonies was picked from each C. difficilepositive specimen; these colonies were examined by toxin gene typing and PCR ribotyping. All isolates from each specimen gave an identical toxin gene type and PCR ribotype in all 34 specimens. Therefore, one isolate from each of the 34 specimens was analysed further by PFGE. All 34 isolates were Composition of the intestinal microflora in C. difficile-positive and -negative subjects Composition of faecal microflora was compared in seven C. difficile-positive (aged 20 23) and nine C. difficilenegative (aged 20 23) subjects in the student group (Table 3). The age distribution of the subjects was adjusted in order to compare the two groups. C. difficile-positive subjects were significantly more densely colonized by enterococci (P, 0. 05) than C. difficile-negative subjects. Moreover, it was shown that all subjects who were found to be C. difficile-positive three or four times were colonized by a concentration of 10 7 enterococci (g stool) 1 or more, in comparison with the nine C. difficile-negative subjects, among whom only one was colonized by a level of 10 7 enterococci (g stool) 1. The other eight subjects in that group were colonized by fewer than 10 7 enterococci (g stool) 1 (Table 4). Percentage colonization and viable counts of other bacteria tested were similar in C. difficilepositive and -negative subjects. DISCUSSION In previous reports of intestinal colonization of healthy adults by C. difficile, colonization rates ranged from 0 to % (Nakamura et al., 1981; Viscidi et al., 1981; Wilson et al., 1982; Kobayashi, 1983; Aronsson et al., 1985). Fekety & Shah (1993) reported that the faeces of about 5 % of healthy adults are colonized by toxigenic C. difficile. In our previous report (Kato et al., 2001), colonization rates of toxigenic and non-toxigenic C. difficile ranged from 4. 2to15. 3 % in the surveyed groups; 4. 5 % of healthy adults were colonized by IP:

4 E. Ozaki and others bp S-1 C-1 hyk ntt ntt ntt M M PCR ribotype kbp S-1 C-1 R112 R115 R115 R115 M M PFGE patterns Fig. 1. Representative PCR ribotypes and PFGE patterns of C. difficile isolates. M, Standard 100 bp DNA ladders (PCR ribotype) and chromosomal DNA from Saccharomyces cerevisiae (PFGE patterns) as molecular size standards; lanes 1 4, isolates from S-1 of the student group; lanes 5 8, isolates from C-1 of the employee group. Table 3. Composition of faecal microflora in C. difficile-positive and -negative subjects Microbe C. difficile-positive (n 7) C. difficile-negative (n 9) Positive (%) Viable count (log c.f.u.) g 21 Positive (%) Viable count (log c.f.u.) g 21 Median Range Median Range Anaerobes (total) Bacteroides Bifidobacteria , , Clostridia (L+)* , , 2.30, Lactobacilli , , Aerobes (total) Enterobacteriaceae Enterococci Staphyloccoci , , *L+: Lecithinase-positive. P, 0.05 (Mann Whitney U test). Table 4. Viable counts of enterococci in the faeces of C. difficilepositive and -negative subjects Viable count (c.f.u. g 21 ) No. subjects who were C. difficile-positive at n examinations toxigenic C. difficile. In this study, colonization rates of toxigenic and non-toxigenic C. difficile ranged from 2. 4to % in seven inspections (Table 1), and that of toxigenic C. difficile was 4. 0 % overall. Colonization rates in the present study were similar to those in previous reports. In our previous paper, we reported the possibility that crosstransmission of C. difficile can occur not only in nosocomial settings, but also among healthy adults in community settings (Kato et al., 2001). In this study, C. difficile strains with the same PCR ribotype/pfge type were isolated from different subjects in the employee group. These results suggest that cross-transmission of C. difficile may be relatively common among healthy individuals. However, there is a possibility that spread was due to a common source of C. difficile in the work environment. Further studies are required to clarify this point. In our previous report, C. difficile was reisolated from 32 % of C. difficile-positive subjects after an interval of 6 months; 50 % of these individuals harboured a different strain on the second investigation (Kato et al., 2001). Among the 18 C. difficile-positive subjects in the present study, the number of subjects from whom C. difficile was isolated once was 10 (55. 6 %), and the number of subjects from whom C. difficile was isolated twice, three times or four times was eight 170 IP: Journal of Medical Microbiology 53

5 C. difficile colonization in healthy adults (44. 4 %) (Table 2). Among these eight subjects, only three (37. 5 %) were colonized continuously by the same strains. These results demonstrate that colonization of healthy individuals by C. difficile is transient in many cases. However, the present study indicates clearly that there are healthy individuals who are continuously colonized by C. difficile, although this is rare. In all three subjects who were C. difficilepositive four times (S-1, S-2 and C-1), the C. difficile isolates from each subject were different from each other and only one of the three subjects (S-1) harboured the same type continuously. These findings suggest that factors other than bacterial properties of C. difficile strains may play an important role in continuous colonization by C. difficile. Considering that all five subjects (S-1, S-2, S-3, C-1 and C-2) from whom C. difficile was isolated three or four times harboured organisms of the same type on at least two consecutive examinations, the subjects themselves may have contaminated their environment, leading in turn to repeated infections from the environment. To examine possible host-related factors that may affect colonization by C. difficile, we examined the hosts microflora and found that the number of enterococci in faeces was significantly higher among C. difficile-positive subjects. In addition, we recently encountered two additional students who were colonized persistently by C. difficile, who were also colonized by a level of enterococci that exceeded 10 8 (g stool) 1 (data not shown). Hopkins & Macfarlane (2002) also demonstrated that levels of enterococci were higher in the faeces of CDAD patients, compared to healthy adults. Interestingly, colonization by C. difficile occurs at high frequency in infants (Stark et al., 1982), who are generally colonized densely by enterococci (Mitsuoka et al., 1974). Taken together, these data suggest that dense colonization of the intestine by enterococci may be associated with C. difficile colonization. Interactions between C. difficile and intestinal flora have been discussed in the literature. Growth and colonization of C. difficile was shown to be inhibited by the following factors of other intestinal flora: depletion of amino acids, decrease in ph, presence of volatile fatty acids (Yamamoto-Osaki et al., 1994) and competition for association with mucosal surfaces, mucin and N-acetylglucosamine (Borriello, 1990). In this study, we examined whether or not the culture supernatants of enterococci have an effect on the rate of germination of C. difficile spores (the germination frequency of which was found to be quite low; Nakamura et al., 1985) and on the binding of C. difficile to cultured cells; however, in neither of these cases were any effects observed (data not shown). The reason for dense colonization of C. difficile-positive individuals by enterococci remains unknown; further studies will be required to account for these findings. ACKNOWLEDGEMENTS We would like to thank T. Muraki of the Ishikawa Yakult Company for sample collection. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Yakult Bio-Science Foundation, Japan. REFERENCES Aronsson, B., Mollby, R. & Nord, C. E. (1985). Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, J Infect Dis 151, Borriello, S. P. (1990). The influence of the normal flora on Clostridium difficile colonisation of the gut. Ann Med 22, Cartmill, T. D., Panigrahi, H., Worsley, M. A., McCann, D. C., Nice, C. N. & Keith, E. (1994). Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect 27, Fekety, R. & Shah, A. B. (1993). Diagnosis and treatment of Clostridium difficile colitis. JAMA 269, Gerding, D. N., Olson, M. M., Peterson, L. R., Teasley, D. G., Gebhard, R. L., Schwartz, M. L. & Lee, J. T., Jr (1986). Clostridium difficileassociated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med 146, Hopkins, M. J. & Macfarlane, G. T. (2002). Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51, Kato, H., Kato, N., Watanabe, K. & 7 other authors (1998). Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 36, Kato, H., Kita, H., Karasawa, T. & 7 other authors (2001). Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol 50, Kobayashi, T. (1983). Studies on Clostridium difficile and antimicrobial associated diarrhoea or colitis. Jpn J Antibiot 36, (in Japanese). Lyerly, D. M., Krivan, H. C. & Wilkins, T. D. (1988). Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1, Mitsuoka, T., Hayakawa, K. & Kimura, N. (1974). The faecal flora of man. II. The composition of bifidobacterial flora of different age groups. Zentbl Bakteriol Hyg I Abt Orig A 226, (in German). Morotomi, M., Takayama, H., Nanno, M., Tanaka, R., Kawai, Y. & Mutai, M. (1981). Significance of fecal medium for human intestinal microflora. In Recent Advances in Germfree Research, pp Edited by S. Sakaki, A. Ozawa & K. Hashimoto. Kanagawa, Japan: Tokai University Press. Nakamura, S., Mikawa, M., Nakashio, S., Takabatake, M., Okado, I., Yamakawa, K., Serikawa, T., Okumura, S. & Nishida, S. (1981). Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults. Microbiol Immunol 25, Nakamura, S., Yamakawa, K., Izumi, J., Nakashio, S. & Nishida, S. (1985). Germinability and heat resistance of spores of Clostridium difficile strains. Microbiol Immunol 29, Petts, D. N. (1984). Colistin-oxolinic acid-blood agar: a new selective medium for streptococci. J Clin Microbiol 19,4 7. Samore, M. H., Venkataraman, L., DeGirolami, P. C., Arbeit, R. D. & Karchmer, A. W. (1996). Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 100, Stark, P. L., Lee, A. & Parsonage, B. D. (1982). Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun 35, Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromo- IP:

6 E. Ozaki and others somal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, Viscidi, R., Willey, S. & Bartlett, J. G. (1981). Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology 81,5 9. Wilson, K. H., Silva, J. & Fekety, F. R. (1982). Fluorescent-antibody test for detection of Clostridium difficile in stool specimens. J Clin Microbiol 16, Yamamoto-Osaki, T., Kamiya, S., Sawamura, S., Kai, M. & Ozawa, A. (1994). Growth inhibition of Clostridium difficile by intestinal flora of infant faeces in continuous flow culture. J Med Microbiol 40, IP: Journal of Medical Microbiology 53

(PFGE) Clostridium di$cile

(PFGE) Clostridium di$cile 2009 205 (PFGE) Clostridium di$cile 1) 3) 2) 2) 2) 2, 4) 5) 1) 2) 3) 4) 5) 21 5 22 21 8 31 2004 1 2008 12 5 Clostridium di$cile (C. di$cile) 340 248 A /B 141 (56.9) A /B 26 (10.5) A /B 81 (32.7) 136 (PFGE)

More information

Reduction of Population Levels of Some Indigenous Bacteria by Lactobacilli in the Gastrointestinal Tract of Gnotobiotic Rats

Reduction of Population Levels of Some Indigenous Bacteria by Lactobacilli in the Gastrointestinal Tract of Gnotobiotic Rats Microbiol. Immunol. Vol. 21 (9), 495-503, 1977 Reduction of Population Levels of Some Indigenous Bacteria by Lactobacilli in the Gastrointestinal Tract of Gnotobiotic Rats Tsugio WATANABE, Masami MOROTOMI,

More information

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017)

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) What is Clostridium difficile? Clostridium difficile is a Gram-positive anaerobic spore forming bacillus. It is ubiquitous in nature and

More information

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click

More information

Probiotics for Primary Prevention of Clostridium difficile Infection

Probiotics for Primary Prevention of Clostridium difficile Infection Probiotics for Primary Prevention of Clostridium difficile Infection Objectives Review risk factors for Clostridium difficile infection (CDI) Describe guideline recommendations for CDI prevention Discuss

More information

C lostridium difficile is an anaerobic Gram positive bacillus

C lostridium difficile is an anaerobic Gram positive bacillus 673 GASTROINTESTINAL INFECTION Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of S S Johal, J Hammond, K Solomon, P D James, Y R Mahida...

More information

Ecology of Bifidobacterium in the Human Intestinal Flora

Ecology of Bifidobacterium in the Human Intestinal Flora Review Bifidobacteria Microflora Vol. 6(2), 33-41, 1987 Ecology of Bifidobacterium in the Human Intestinal Flora Masahiko MUTAI and Ryuichiro TANAKA* Yakult Central Institute, 1796 Yaho, Kunitachi, Tokyo,

More information

INDIVIDUAL STUDY SYNOPSIS LINPT01. EudraCT No

INDIVIDUAL STUDY SYNOPSIS LINPT01. EudraCT No NAME OF SPONSOR: Lek Pharmaceuticals d.d. Verovškov 57 SI-1526 Ljubljana NAME OF FINISHED PRODUCT: Linef Forte, trde kapsule INDIVIDUAL STUDY SYNOPSIS LINPT01 EudraCT No.2009-010713-69 NAME OF ACTIVE INGREDIENTS:

More information

Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose?

Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? March 9, 0 http://www.slh.wisc.edu/outreach-data/event-detail.php?id=03 Raymond P. Podzorski, Ph.D., D(ABMM) Clinical Microbiologist

More information

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE

ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE The diagnosis of CDI should be based on a combination of clinical and laboratory findings. A case definition for the usual

More information

Laboratory report. Test: Leaky gut test. Sample material: stool. John Doe Main St 1 Anytown

Laboratory report. Test: Leaky gut test. Sample material: stool. John Doe Main St 1 Anytown 1 / 5 Verisana LAB John Doe Main St 1 Anytown Surname, First name Doe, John DOB 02/13/1980 Sex male Laboratory # 20020181 Date collected 01/25/2018 Date received 02/01/2018 Report date 02/13/2018 Laboratory

More information

Colonization of the Large Bowel by Clostridium difficile in Healthy Infants: Quantitative Study

Colonization of the Large Bowel by Clostridium difficile in Healthy Infants: Quantitative Study INFECriON AND IMMUNITY, Mar. 1982, p. 895-899 Vol. 35, No. 3 0019-9567/82/030895-05$02.00/0 Colonization of the Large Bowel by Clostridium difficile in Healthy Infants: Quantitative Study PAMELA L. STARK,

More information

Antibiotic treatment comparison in patients with diarrhea

Antibiotic treatment comparison in patients with diarrhea Original Research Article Antibiotic treatment comparison in patients with diarrhea Deva Lal Kast * Senior Consultant Physician, Department of General Medicine, Krishna Hospital, Ex senior Specialist and

More information

complicating inflammatory bowel disease

complicating inflammatory bowel disease Gut, 1982, 23, 410-414 Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease M R B KEIGHLEY*, DENISE YOUNGS, MARGARET JOHNSON, R N ALLAN, and D W BURDON From The General

More information

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH

The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH The Epidemiology of Clostridium difficile DANIEL SAMAN, DRPH, MPH RESEARCH SCIENTIST ESSENTIA INSTITUTE OF RURAL HEALTH Some history first Clostridium difficile, a spore-forming gram-positive (i.e., thick

More information

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments

March 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments March 3, 2010 To: Hospitals, Long Term Care Facilities, and Local Health Departments From: NYSDOH Bureau of Healthcare Associated Infections HEALTH ADVISORY: GUIDANCE FOR PREVENTION AND CONTROL OF HEALTHCARE

More information

were obtained from the American Type Culture Collection obtained from the National Collection of Type Cultures,

were obtained from the American Type Culture Collection obtained from the National Collection of Type Cultures, JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1985, p. 323-327 0095-1137/85/030323-05$02.00/0 Copyright ( 1985, American Society for Microbiology Vol. 21, No. 3 Serogrouping of Clostridium difficile Strains by

More information

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics

Stony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics Stony Brook Adult Clostridium difficile Management Guidelines Summary: Use of the C Diff Infection (CDI) PowerPlan (Adult) Required Patient with clinical findings suggestive of Clostridium difficile infection

More information

ABSTRACT PURPOSE METHODS

ABSTRACT PURPOSE METHODS ABSTRACT PURPOSE The purpose of this study was to characterize the CDI population at this institution according to known risk factors and to examine the effect of appropriate evidence-based treatment selection

More information

!Microbiology Profile, stool

!Microbiology Profile, stool LAB #: F000000-0000-0 PATIENT: Sample Patient ID: P12345 SEX: Female AGE: 37 CLIENT #: 12345 DOCTOR: Doctor's Data, Inc. 3755 Illinois Ave. St. Charles, IL 60174!Microbiology Profile, stool BACTERIOLOGY

More information

Rapid-VIDITEST C. difficile Ag (GDH) Card/Blister

Rapid-VIDITEST C. difficile Ag (GDH) Card/Blister Li StarFish S.r.l. Via Cavour, 35-20063 Cernusco S/N (MI), Italy Tel. +39-02-92150794 - Fax. +39-02-92157285 info@listarfish.it -www.listarfish.it Rapid-VIDITEST C. difficile Ag (GDH) Card/Blister One

More information

INTESTINAL MICROBIOTA EXAMPLES OF INDIVIDUAL ANALYSES

INTESTINAL MICROBIOTA EXAMPLES OF INDIVIDUAL ANALYSES EXAMPLES OF INDIVIDUAL ANALYSES INTESTINAL MICROBIOTA Microbiota in the animal or human intestine has evolved together with the host. Consequently, the gastrointestinal tract could be considered a metacommunity,

More information

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment.

The incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment. C. DIFFICILE Case definition CONFIRMED CASE A patient is defined as a case if they are one year of age or older AND have one of the following requirements: A laboratory confirmation of a positive toxin

More information

Factors associated with prolonged symptoms and severe disease due to Clostridium difficile

Factors associated with prolonged symptoms and severe disease due to Clostridium difficile Age and Ageing 1999; 28: 107 113 Factors associated with prolonged symptoms and severe disease due to Clostridium difficile LORRAINE KYNE, CONCEPTA MERRY 2,BRIAN O CONNELL 2,ALAN KELLY 3,CONOR KEANE 2,

More information

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013

Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013 Division of GIM Lecture Series Case Presentation David A. Erickson, M.D October 9th, 2013 Financial Disclosures No financial disclosures Objectives Review a case of recurrent Clostridium difficile infection

More information

Molecular Epidemiology of Hospital-Associated and Community-Acquired Clostridium difficile Infection in a Swedish County

Molecular Epidemiology of Hospital-Associated and Community-Acquired Clostridium difficile Infection in a Swedish County JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2004, p. 3635 3643 Vol. 42, No. 8 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.8.3635 3643.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.

More information

COMPARISON OF THE PREVALENCE AND GENOTYPIC CHARACTERISTICS OF CLOSTRIDIUM DIFFICILE IN A CLOSED AND INTEGRATED HUMAN AND SWINE POPULATION IN TEXAS

COMPARISON OF THE PREVALENCE AND GENOTYPIC CHARACTERISTICS OF CLOSTRIDIUM DIFFICILE IN A CLOSED AND INTEGRATED HUMAN AND SWINE POPULATION IN TEXAS COMPARISON OF THE PREVALENCE AND GENOTYPIC CHARACTERISTICS OF CLOSTRIDIUM DIFFICILE IN A CLOSED AND INTEGRATED HUMAN AND SWINE POPULATION IN TEXAS A Dissertation by KERI NOELLE NORMAN Submitted to the

More information

SMT19969: A Selective Therapy for C. difficile Infection

SMT19969: A Selective Therapy for C. difficile Infection SMT19969: A Selective Therapy for C. difficile Infection One Bug, One Drug 25 th September 2012 SMT19969: A Selective Therapy for CDI SMT19969 is a novel antibiotic for the specific treatment of Clostridium

More information

Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children

Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children Journal of Medical Microbiology (2005), 54, 987 991 DOI 10.1099/jmm.0.46101-0 Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children Helena M.

More information

Le infezioni da Clostridium difficile, gravi, ricorrenti e complicate Nicola Petrosillo

Le infezioni da Clostridium difficile, gravi, ricorrenti e complicate Nicola Petrosillo Le infezioni da Clostridium difficile, gravi, ricorrenti e complicate Nicola Petrosillo Istituto Nazionale per le Malattie Infettive «lazzaro Spallanzani», IRCCS-Roma The infectious cycle of transmission

More information

Introduction ORIGINAL ARTICLE 1

Introduction ORIGINAL ARTICLE 1 ORIGINAL ARTICLE 1 Laboratory diagnosis of Clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author ECDIS-NET: Update on Clostridium difficile epidemiology in Europe 1 E d J. K u i j p e r, S o f i e v a n D o r p a n d D a a n N o t e r m a n s. D e p a r t m e n t o f M e d i c a l M i c r o b i o

More information

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review

Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review October 18, 2010 James Kahn and Carolyn Kenney, MSIV Overview Burden of disease associated

More information

Update on Clostridium difficile infection.

Update on Clostridium difficile infection. Update on Clostridium difficile infection. K. Honein Gastroenterologist, HDF Associate Professor Head of Medicine Department St Joseph University-Beirut. Introduction Gram+anaerobic bacillus responsible

More information

השפעת חיידקים פרוביוטיים

השפעת חיידקים פרוביוטיים השפעת חיידקים פרוביוטיים החיים בחלל )המעי(... על רון שאול יחידת גסטרו ילדים מרכז רפואי רמב"ם Introduction The intestinal microflora primarily in the large bowel consists mostly on benign bacterial species

More information

ESTABLISHMENT AND DEVELOPMENT OF LACTIC ACID BACTERIA AND BIFIDOBACTERIA MICROBIOTA IN BREAST-MILK AND THE INFANT GUT

ESTABLISHMENT AND DEVELOPMENT OF LACTIC ACID BACTERIA AND BIFIDOBACTERIA MICROBIOTA IN BREAST-MILK AND THE INFANT GUT Text 1 ESTABLISHMENT AND DEVELOPMENT OF LACTIC ACID BACTERIA AND BIFIDOBACTERIA MICROBIOTA IN BREAST-MILK AND THE INFANT GUT Solís G. a, de los Reyes-Gavilan C.G. b, Fernández N. a, Margolles A. b and

More information

Materials EXCLUSION CRITERIA INCLUSION CRITERIA

Materials EXCLUSION CRITERIA INCLUSION CRITERIA Bifidobacteria numbers in colon of children with inflammatory bowel disease (IBD). Gosiewski T 1, Kochan P 1,StrusM 1, Brzychczy-Wloch M 1, Drzewiecki A 1, Kowalska-Duplaga K 2, Wedrychowicz A 2, Jedynak-Wasowicz

More information

Molecular epidemiology of Clostridium difficile infection in British Columbia, Canada

Molecular epidemiology of Clostridium difficile infection in British Columbia, Canada Molecular epidemiology of Clostridium difficile infection in British Columbia, Canada Agatha Jassem, PhD Senior Scientist, BCCDC Public Health Laboratory Objectives Molecular typing methods for C. difficile

More information

Role of Klebsiella oxytoca in Antibiotic-Associated Diarrhea

Role of Klebsiella oxytoca in Antibiotic-Associated Diarrhea MAJOR ARTICLE Role of Klebsiella oxytoca in Antibiotic-Associated Diarrhea Ines Zollner-Schwetz, 1 Christoph Högenauer, 2 Martina Joainig, 2 Paul Weberhofer, 2 Gregor Gorkiewicz, 3 Thomas Valentin, 1 Thomas

More information

Poultry The unique probiotic

Poultry The unique probiotic Poultry The unique probiotic Probiotics Probiotics have been defined as live microbial feed supplements which beneficially affect the host animal by improving its intestinal microbial balance. Achieving

More information

sc, 1985 The Pathological Society of Great Britain and Ireland

sc, 1985 The Pathological Society of Great Britain and Ireland J. MED. MICROBIOL. --VOL. 9 (985). 339-35 sc, 985 The Pathological Society of Great Britain and Ireland PROTECTION OF HAMSTERS AGAINST CLOSTRIDIUM DIFFICILE ILEOCAECITIS BY PRIOR COLONISATTON WITH NON-PATHOGENIC

More information

Nobuyuki SUZUKI 1, 2, Yuji AIBA 1, 2, Hiroyuki TAKEDA 3, Yasunori FUKUMORI 3 and Yasuhiro KOGA 1*

Nobuyuki SUZUKI 1, 2, Yuji AIBA 1, 2, Hiroyuki TAKEDA 3, Yasunori FUKUMORI 3 and Yasuhiro KOGA 1* Full Paper Bioscience Microflora Vol. 25 (3), 109 116, 2006 Superiority of 1-kestose, the Smallest Fructo-oligosaccharide, to a Synthetic Mixture of Fructo-oligosaccharides in the Selective Stimulating

More information

Clostridium difficile

Clostridium difficile Clostridium difficile Care Homes IPC Study Day Sue Barber Infection Prevention & Control Lead AV & Chiltern CCG s Clostridium difficile A spore forming Bacterium. Difficult to grow in the laboratory hence

More information

Clostridium difficile Infection (CDI) Management Guideline

Clostridium difficile Infection (CDI) Management Guideline Clostridium difficile Infection (CDI) Management Guideline Do not test all patients with loose or watery stools for CDI o CDI is responsible for

More information

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats Jean B. Patel, PhD, D(ABMM) Science Lead, Antibiotic Resistance and Coordination Unit Centers for

More information

CLOSTRIDIUM DIFICILE. Negin N Blattman Infectious Diseases Phoenix VA Healthcare System

CLOSTRIDIUM DIFICILE. Negin N Blattman Infectious Diseases Phoenix VA Healthcare System CLOSTRIDIUM DIFICILE Negin N Blattman Infectious Diseases Phoenix VA Healthcare System ANTIBIOTIC ASSOCIATED DIARRHEA 1978: C diff first identified 1989-1992: Four large outbreaks in the US caused by J

More information

Gerald W. Tannock, 1 Ing Soo Tiong, 2 Patricia Priest, 3 Karen Munro, 1 Corinda Taylor, 1 Alice Richardson 1 and Michael Schultz 2 INTRODUCTION

Gerald W. Tannock, 1 Ing Soo Tiong, 2 Patricia Priest, 3 Karen Munro, 1 Corinda Taylor, 1 Alice Richardson 1 and Michael Schultz 2 INTRODUCTION Journal of Medical Microbiology (2011), 60, 366 370 DOI 10.1099/jmm.0.025874-0 Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant

More information

Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others

Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 48 Bacterial Enteric Pathogens: Clostridium difficile, Salmonella, Shigella, Escherichia coli, and others Authors Olivier Vandenberg, MD, PhD Michèle

More information

The effect of probiotics on animal health: a focus on host s natural intestinal defenses

The effect of probiotics on animal health: a focus on host s natural intestinal defenses The effect of probiotics on animal health: a focus on host s natural intestinal defenses Guillaume Tabouret Animal Health Dept. Joint Unit 1225 Host Pathogens Interactions History of probiotics and definition

More information

ASSESMENT OF CRYOPRESERVATION SYSTEMS INFLUENCE ON THE SURVAVIAL OF E. COLI RECOMBINANT STRAINS

ASSESMENT OF CRYOPRESERVATION SYSTEMS INFLUENCE ON THE SURVAVIAL OF E. COLI RECOMBINANT STRAINS Lucrări ştiinńifice Zootehnie şi Biotehnologii, vol. 41(1) (2008), Timişoara ASSESMENT OF CRYOPRESERVATION SYSTEMS INFLUENCE ON THE SURVAVIAL OF E. COLI RECOMBINANT STRAINS TESTAREA INFLUENłEI SISTEMELOR

More information

D DAVID PUBLISHING. Double Problem Clostridium difficile and Diabetes. 1. Introduction. Ioana Florina Iordan 1 and Carmen Manciuc 1, 2

D DAVID PUBLISHING. Double Problem Clostridium difficile and Diabetes. 1. Introduction. Ioana Florina Iordan 1 and Carmen Manciuc 1, 2 Journal of Pharmacy and Pharmacology 6 (2018) 170-174 doi: 10.17265/2328-2150/2018.02.010 D DAVID PUBLISHING Ioana Florina Iordan 1 and Carmen Manciuc 1, 2 1. Sf. Paracheva Infectious Diseases Hospital,

More information

of Shigella with Bifidobacteria

of Shigella with Bifidobacteria Bifidobacteria Microflora Vol. 5(1), 51-55, 1986 Interaction of Shigella with Bifidobacteria Noboru OKAMURA,1* Rintaro NAKAYA,1 Hajime YOKOTA,2 Nobuya YANAI2 and Takuji KAWASHIMA2 Department of Microbiology,

More information

INTRODUCING YOUR GUT BACTERIA

INTRODUCING YOUR GUT BACTERIA INTRODUCING YOUR GUT BACTERIA Microflora Intestinal flora 1.5 kg We would die with 5 years of birth if we did not have them as we would not develop a proper immune system 1000 species and 5000 strains

More information

Polyclonality of Staphylococcus epidermidis residing on the healthy ocular surface

Polyclonality of Staphylococcus epidermidis residing on the healthy ocular surface Journal of Medical Microbiology (2007), 56, 77 82 DOI 10.1099/jmm.0.46810-0 Polyclonality of Staphylococcus epidermidis residing on the healthy ocular surface Mayumi Ueta, 1 Tetsuya Iida, 2 Masako Sakamoto,

More information

GI Bacterial Infections (part-1)

GI Bacterial Infections (part-1) GI Bacterial Infections (part-1) Mohammed Abdulla Mehdi FIBMS (internal medicine), FIBMS (Gastroenterology & Hepatology) Acute diarrhea and vomiting Acute diarrhea, sometimes with vomiting, is the predominant

More information

The Potential For Microbiome Modification In Critical Illness. Deborah Cook

The Potential For Microbiome Modification In Critical Illness. Deborah Cook The Potential For Microbiome Modification In Critical Illness Deborah Cook To review Objectives The microbiome & concepts about its modification during critical illness Interventions Predisposition to

More information

The Effects of Reiki on Bacteria Survivorship. Jordan Ciccone Central Catholic High School

The Effects of Reiki on Bacteria Survivorship. Jordan Ciccone Central Catholic High School The Effects of Reiki on Bacteria Survivorship Jordan Ciccone Central Catholic High School Reiki Japanese spiritual healing practice meaning universal life energy. Training is done by a Reiki Master. Either

More information

Bacteriology. Mycology. Patient: SAMPLE PATIENT DOB: Sex: MRN: Rare. Rare. Positive. Brown. Negative *NG. Negative

Bacteriology. Mycology. Patient: SAMPLE PATIENT DOB: Sex: MRN: Rare. Rare. Positive. Brown. Negative *NG. Negative Patient: SAMPLE PATIENT DOB: Sex: MRN: 3.2 0.9-26.8 U/g 1.2 0.2-3.3 mg/g 2.2 1.3-8.6 micromol/g 1.1 1.3-23.7 mg/g 1.1 0.2-3.5 mg/g Rare 1.0 0.2-8.8 mg/g Rare 4.4 2.6-32.4 mg/g 64.6 >= 13.6 micromol/g Bacteriology

More information

Characterization of community and hospital Staphylococcus aureus isolates in Southampton, UK

Characterization of community and hospital Staphylococcus aureus isolates in Southampton, UK Journal of Medical Microbiology (2010), 59, 1084 1088 DOI 10.1099/jmm.0.018986-0 Characterization of community and hospital Staphylococcus aureus isolates in Southampton, UK S. M. Green, 1 P. Marsh, 1

More information

White Rose Research Online URL for this paper:

White Rose Research Online URL for this paper: This is an author produced version of Efficacy of vancomycin extended dosing regimens for treatment of simulated Clostridium difficile infection (CDI) within an in vitro human gut model. White Rose Research

More information

GUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS

GUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS GUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS Version 3.0 Date ratified May 2008 Review date May 2010 Ratified by NUH Antibiotic Guidelines Committee NUH Drugs and Therapeutics

More information

Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela

Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela Chapter 19 Prevention of Healthcare- Associated Gastrointestinal Infections Michael A. Borg and Rodianne Abela Key Points Noroviruses are the commonest cause of healthcare-associated gastroenteritis. Isolation

More information

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011

Clostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Clostridium Difficile Associated Disease Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Introduction Which of the following is more common in community hospitals in the Southeast

More information

Whole genome sequencing & new strain typing methods in IPC. Lyn Gilbert ACIPC conference Hobart, November 2015

Whole genome sequencing & new strain typing methods in IPC. Lyn Gilbert ACIPC conference Hobart, November 2015 Whole genome sequencing & new strain typing methods in IPC Lyn Gilbert ACIPC conference Hobart, November 2015 Why do strain typing? Evolution, population genetics, geographic distribution 2 Why strain

More information

A Pharmacist Perspective

A Pharmacist Perspective Leveraging Technology to Reduce CDI A Pharmacist Perspective Ed Eiland, Pharm.D., MBA, BCPS (AQ-ID) Clinical Practice and Business Supervisor Huntsville Hospital System Huntsville Hospital 881 licensed

More information

Modern approach to Clostridium Difficile Infection

Modern approach to Clostridium Difficile Infection Modern approach to Clostridium Difficile Infection Pseudomembranous Colitis: Principles for diagnosis and treatment Aggelos Stefos Internist, Infectious diseases Specialist Department of Medicine and Research

More information

Administration of Bifidobacterium to Infants with Atopic Dermatitis: Changes in Fecal Microflora and Clinical Symptoms

Administration of Bifidobacterium to Infants with Atopic Dermatitis: Changes in Fecal Microflora and Clinical Symptoms Administration of Bifidobacterium to Infants with Atopic Dermatitis: Changes in Fecal Microflora and Clinical Symptoms Shoichiro Taniuchi, MD * Kazuhiro Hattori, MD * Akemi Yamamoto, MD * Misa Sasai, MD

More information

SHORT REPORT Infant botulism with prolonged faecal excretion of botulinum neurotoxin and Clostridium botulinum for 7 months

SHORT REPORT Infant botulism with prolonged faecal excretion of botulinum neurotoxin and Clostridium botulinum for 7 months Epidemiol. Infect., Page 1 of 5. Cambridge University Press 2013 doi:10.1017/s0950268813001258 SHORT REPORT Infant botulism with prolonged faecal excretion of botulinum neurotoxin and Clostridium botulinum

More information

Persistence of Skin Contamination and Environmental Shedding of Clostridium difficile during and after Treatment of C. difficile Infection

Persistence of Skin Contamination and Environmental Shedding of Clostridium difficile during and after Treatment of C. difficile Infection infection control and hospital epidemiology january 2010, vol. 31, no. 1 original article Persistence of Skin Contamination and Environmental Shedding of Clostridium difficile during and after Treatment

More information

The faecal flora of two patients with food-related irritable bowel syndrome during challenge with symptom - provoking foods

The faecal flora of two patients with food-related irritable bowel syndrome during challenge with symptom - provoking foods J. Med. Microbiol. - Vol. 6 (), - The Pathological Society of Great Britain and Ireland The faecal flora of two patients with food-related irritable bowel syndrome during challenge with symptom - provoking

More information

Patient Safety Summit 2014

Patient Safety Summit 2014 Patient Safety Summit 2014 The War on C Diff Mark Mellow, MD + C Diff The Organism Gram + bacillus Anaerobic Spore forming Intestinal flora (up to 35% hospitalized patients, 3% of healthy adults) Leading

More information

PROBIONA. PROBIOTICS with 5 bacterial strains. Suitable during and after the use of antibiotics to restore intestinal microflora.

PROBIONA. PROBIOTICS with 5 bacterial strains. Suitable during and after the use of antibiotics to restore intestinal microflora. PROBIONA Probiotic supplement for adults PROBIOTICS with 5 bacterial strains Suitable during and after the use of antibiotics to restore intestinal microflora. 2.850 billion cfu per capsule guaranteed

More information

Reference assays for Clostridium difficile infection: one or two gold standards?

Reference assays for Clostridium difficile infection: one or two gold standards? 1 Centre for Infection, Division of Cellular and Molecular Medicine, St George s University of London, Cranmer Terrace, London, UK 2 Microbiology, Leeds Teaching Hospitals and University of Leeds, Old

More information

1) 1) 1) 2) 2) (ICU) Key words: (ICU), ( ) 1 30 TEL: FAX: Vol. 17 No

1) 1) 1) 2) 2) (ICU) Key words: (ICU), ( ) 1 30 TEL: FAX: Vol. 17 No 2007 277 1) 1) 1) 2) 2) 3) 4) 5) 6) 1) 2) 3) 4) 5) 6) 18 10 17 19 8 20 16 7 1 (ICU) 20 2x 1.6 2.2 2SD 14 1 4 1 10 7 3 2 9 7.6; 95 2.37 24.62 6 4 5 1 DNA SpeI 9 2 A 7 B 2 A 3 B 1 ICU ICU 7 20 10 5 Key words:

More information

Prenatal and neonatal gut maturation

Prenatal and neonatal gut maturation Department of Veterinary Clinical and Animal Sciences Prenatal and neonatal gut maturation Thomas Thymann Comparative Pediatrics and Nutrition Dept. Vet. and Animal Science P.W. Nathanielsz Whom signals

More information

Understanding probiotics and health

Understanding probiotics and health Understanding probiotics and health Gemma Laws MSc Student Microbiology and Immunology Department The gut microbiota The name given to the total microbial population living in our intestine Bacteria, fungi,

More information

Bacteriology. Mycology. Genova Diagnostics SAMPLE REPORT. Rare. Rare. Negative. Brown. Negative *NG. Negative

Bacteriology. Mycology. Genova Diagnostics SAMPLE REPORT. Rare. Rare. Negative. Brown. Negative *NG. Negative Completed: November 2010 Genova Diagnostics eceived: October 2010 Collected: October 2010 oute Number:7 4.2 0.9-26.8 U/g 0.9 0.2-3.3 mg/g 0.8 1.3-8.6 micromol/g 42.7 1.3-23.7 mg/g 1.7 0.2-3.5 mg/g are

More information

Nicola Petrosillo Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, IRCCS Roma. L infezione da C difficile grave o complicata

Nicola Petrosillo Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, IRCCS Roma. L infezione da C difficile grave o complicata Nicola Petrosillo Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, IRCCS Roma L infezione da C difficile grave o complicata Bagdasarian N et al. JAMA 2015; 313: 398-408 European Society

More information

Microbiome GI Disorders

Microbiome GI Disorders Microbiome GI Disorders Prof. Ram Dickman Neurogastroenterology Unit Rabin Medical Center Israel 1 Key Points Our gut microbiota Were to find them? Symbiosis or Why do we need them? Dysbiosis or when things

More information

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015 Controversies and Current Issues in Diagnosis, Surveillance, and Treatment of Clostridium difficile infeciton L. Clifford McDonald, MD Senior Advisor for Science and Integrity September 16, 2015 Division

More information

URINARY AND FAECAL ESCHERICHIA COLI O-SERO- GROUPS IN SYMPTOMATIC URINARY-TRACT INFECTION AND ASYMPTOMATIC BACTERIURIA

URINARY AND FAECAL ESCHERICHIA COLI O-SERO- GROUPS IN SYMPTOMATIC URINARY-TRACT INFECTION AND ASYMPTOMATIC BACTERIURIA URINARY AND FAECAL ESCHERICHIA COLI O-SERO- GROUPS IN SYMPTOMATIC URINARY-TRACT INFECTION AND ASYMPTOMATIC BACTERIURIA A. P. ROBERTS, J. D. LINTON, A. M. WATERMAN, P. E. GOWER, K. G. KOUTSAIMANIS Department

More information

Incidence of and risk factors for communityassociated Clostridium difficile infection

Incidence of and risk factors for communityassociated Clostridium difficile infection University of Iowa Iowa Research Online Theses and Dissertations 2010 Incidence of and risk factors for communityassociated Clostridium difficile infection Jennifer Lee Kuntz University of Iowa Copyright

More information

Clostridium difficile Infection (CDI) Guideline Update:

Clostridium difficile Infection (CDI) Guideline Update: Clostridium difficile Infection (CDI) Guideline Update: Understanding the Data Behind the Recommendations Erik R. Dubberke, MD, MSPH A Webinar for HealthTrust Members Professor of Medicine September 24,

More information

'Normalization' of germfree mice after direct and indirect contact with mice having a 'normal' intestinal microflora

'Normalization' of germfree mice after direct and indirect contact with mice having a 'normal' intestinal microflora 286 Laboratory Animals (1986) 20, 286-290. 'Normalization' of germfree mice after direct and indirect contact with mice having a 'normal' intestinal microflora J. P. KOOPMAN 1, H. M. KENNIS 1, A. LANKHORST

More information

9/18/2018. The Physiological Roles of the Intestinal Microbiota. Learning Objectives

9/18/2018. The Physiological Roles of the Intestinal Microbiota. Learning Objectives The Physiological Roles of the Intestinal Microbiota Kelly A. Tappenden, Ph.D., R.D., FASPEN Professor and Head, Kinesiology and Nutrition University Distinguished Teacher-Scholar University of Illinois

More information

Antibiotic Resistance and Probiotics - A Metagenomic Viewpoint

Antibiotic Resistance and Probiotics - A Metagenomic Viewpoint Antibiotic Resistance and Probiotics - A Metagenomic Viewpoint Neerja Hajela, PhD General Manager-Science & Regulatory Affairs Yakult Danone India Pvt. Ltd. Outline of the Presentation Global Epidemiology

More information

Twenty years of the hygiene hypothesis. David P Strachan Community Health Sciences St George s, University of London

Twenty years of the hygiene hypothesis. David P Strachan Community Health Sciences St George s, University of London Twenty years of the hygiene hypothesis David P Strachan Community Health Sciences St George s, University of London A little dirt never does any harm... Hay fever, birth order & social class H a y fe v

More information

Issue 3, September usio

Issue 3, September usio Issue 3, September 2014 usio 1 Lactobacillus casei strain Shirota Research Update IMPROVEMENT IN INTESTINAL HEALTH 1. A probiotic fermented milk drink containing Lactobacillus casei strain Shirota improves

More information

Guidance for obtaining faecal specimens from patients with diarrhoea (Background information)

Guidance for obtaining faecal specimens from patients with diarrhoea (Background information) Guidance for obtaining faecal specimens from patients with diarrhoea (Background information) Version 1.0 Date of Issue: January 2009 Review Date: January 2010 Page 1 of 11 Contents 1. Introduction...

More information

Clinical significance of Clostridium dijfficile and its toxins in faeces of immunocompromised children

Clinical significance of Clostridium dijfficile and its toxins in faeces of immunocompromised children 1608 Eijkman-Winkler Laboratory for Medical Microbiology, University Hospital, M J H M Wolfhagen K Meijer A C Fluit R Torensma J Verhoef Hanze Laboratory for Medical Microbiology and Infectious Diseases,

More information

GASTRIC FLORA OF FASTING HEALTHY SUBJECTS AND ITS RELATIONS TO ph

GASTRIC FLORA OF FASTING HEALTHY SUBJECTS AND ITS RELATIONS TO ph GASTRIC FLORA OF FASTING HEALTHY SUBJECTS AND ITS RELATIONS TO ph Pages with reference to book, From 113 To 116 Rakhshanda Baqai, Sarwar J. Zuberi, Pirzada M.A. Siddiqui ( PMRC Research Centre, Jinnah

More information

PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT PROBIOTICS: WHAT ARE THEY, AND HOW DO THEY WORK? Karen Jensen, (Retired ND)

PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT PROBIOTICS: WHAT ARE THEY, AND HOW DO THEY WORK? Karen Jensen, (Retired ND) PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT Karen Jensen, (Retired ND) Today many people are aware of the benefits of maintaining a healthy gut. As a result, probiotic use is becoming ever more popular.

More information

A Norazah, S M Liew, A G M Kamel, Y T Koh, V K E Lim. O r i g i n a l A r t i c l e

A Norazah, S M Liew, A G M Kamel, Y T Koh, V K E Lim. O r i g i n a l A r t i c l e Singapore Med J 2001 Vol 42(1) : 015-019 O r i g i n a l A r t i c l e DNA Fingerprinting of Methicillin-Resistant Staphylococcus Aureus by Pulsed-Field Gel Electrophoresis (PFGE): Comparison of Strains

More information

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis Journal of Medical Microbiology (2004), 53, 879 885 DOI 10.1099/jmm.0.45655-0 Short Communication Correspondence Itzhak Brook ib6@georgetown.edu Received 1 March 2004 Accepted 18 May 2004 Discrepancies

More information

An Outbreak of Necrotizing Enterocolitis Associated with a Novel Clostridium Species in a Neonatal Intensive Care Unit

An Outbreak of Necrotizing Enterocolitis Associated with a Novel Clostridium Species in a Neonatal Intensive Care Unit SUPPLEMENT ARTICLE An Outbreak of Necrotizing Enterocolitis Associated with a Novel Clostridium Species in a Neonatal Intensive Care Unit Michelle J. Alfa, 1,2,a Diane Robson, 1 Maria Davi, 1,2 Kathy Bernard,

More information

9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)

9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI) Clostridium Difficile: Updates on Diagnosis and Treatment Elizabeth Hudson, DO, MPH 9/25/18 Antibiotic-associated diarrhea and colitis were well established soon after widespread use of antibiotics In

More information

Manipulating the gut microbiome

Manipulating the gut microbiome Manipulating the gut microbiome William DePaolo, PhD Associate Professor Medicine Director Center for Microbiome Sciences & Therapeutics University of Washington Microbiota The actual bugs that reside

More information

Clinical Application of Polymerase Chain Reaction to Diagnose Clostridium difficile in Hospitalized Patients With Diarrhea

Clinical Application of Polymerase Chain Reaction to Diagnose Clostridium difficile in Hospitalized Patients With Diarrhea CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2004;2:669 674 Clinical Application of Polymerase Chain Reaction to Diagnose Clostridium difficile in Hospitalized Patients With Diarrhea MICHAEL S. MORELLI, SUSAN

More information

DETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE

DETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE CLINICAL GUIDELINES For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS DETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE Policy Number: PDS 021 Effective Date:

More information